Impact of 10-Valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns Among Children Aged &amp;lt;5 Years and Adults With Human Immunodeficiency Virus Infection: Kenya, 2009–2013

Kobayashi, Miwako; Bigogo, Godfrey; Kim, Lindsay; D. Mogeni, Ondari; Conklin, Laura; Odoyo, Arthur; Odiembo, Herine; Cristina Pimenta, Fabiana; Ouma, Dominic; M. Harris, Aaron; Odero, Kennedy; Milucky, Jennifer; Ouma, Alice; Aol, George; Audi, Allan; Onyango, Clayton; Cosmas, Leonard; Jagero, Geofrey; L. Farrar, Jennifer; da Glória Carvalho, Maria; G. Whitney, Cynthia; F. Breiman, Robert; C. Lessa, Fernanda

doi:10.1093/cid/ciz285

Public

Impact of 10-Valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns Among Children Aged <5 Years and Adults With Human Immunodeficiency Virus Infection: Kenya, 2009–2013

Published in Clinical Infectious Diseases • Apr 3, 2019

Authors:

Miwako Kobayashi

Godfrey Bigogo

Lindsay Kim

Abstract

BACKGROUND: Kenya introduced 10-valent pneumococcal conjugate vaccine (PCV10) among children <1 year in 2011 with catch-up vaccination among children 1-4 years in some areas. We assessed changes in pneumococcal carriage and antibiotic susceptibility patterns in children <5 years and adults. METHODS:...

Subject

Medicine

Carriage

Pneumococcal conjugate vaccine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!